Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
Morgan Stanley (NYSE:MS) initiated coverage on shares of Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO), a global healthcare company specializing in diabetes care and other serious chronic conditions. The ...
clinicaltrialsarena on MSN13h
OCT West Coast 2025: China surpasses US for annual number of clinical trialsGlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
Daily Express US on MSN14h
Ozempic and Zepbound linked to rare eye conditions that could cause blindnessA new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...
Morgan Stanley initiated coverage of Novo Nordisk (NVO) with an Equal Weight rating and DKK 700 price target The firm says near-term U.S.
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Request To Download Free Sample of This Strategic Report @ Highlighted with 89 tables and 75 figures, this 178-page report ?North America Clinical Trials Market 2022-2031 by Product Category (Drugs, ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 80 tables and 70 figures, this 170-page report ?Switzerland Clinical Trials Market 2022-2031 by Product Category (Drugs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback